Table of Contents
- Key Points
- Understanding Atrial Fibrillation and Ablation
- Why Some Patients Need a Second Ablation Procedure
- Study Methods: How the Research Was Conducted
- Key Findings: What the MRI Detected
- Findings for the Roof Line Ablation
- Comparing MRI Gaps with Electrical Mapping
- MRI-Guided Re-Ablation Results
- Clinical Implications: What This Means for Patients
- Study Limitations
- Recommendations for Patients
- Frequently Asked Questions
- Source Information
Key Points
- In a study of 15 patients having a repeat atrial fibrillation ablation, using delayed-enhancement cardiac MRI to guide the procedure successfully re-isolated 95.6% of reconnected pulmonary veins.
- The MRI-guided approach significantly shortened radiofrequency energy time by about 35% compared with conventional procedures, while total procedure time and safety were similar.
- MRI detected more gaps than electrical mapping, including some in veins that were still electrically isolated; these may be dormant gaps that could reconnect later.
- The study was small, single-center, and not randomized, so results may not apply to all patients; larger studies are needed to confirm the findings.
Understanding Atrial Fibrillation and Ablation
Atrial fibrillation (AF) is the most common type of heart rhythm disorder, affecting millions of people worldwide. In AF, the upper chambers of the heart (the atria) beat irregularly and often too fast, which can lead to symptoms like palpitations, shortness of breath, fatigue, and an increased risk of stroke. Many patients with AF are initially treated with medications to control heart rate or rhythm, but when these drugs don't work or cause unacceptable side effects, doctors may recommend a procedure called catheter ablation.
Catheter ablation is a minimally invasive treatment. A doctor threads thin, flexible tubes (catheters) through blood vessels to the heart and delivers radiofrequency (RF) energy to create tiny, targeted burns (lesions) in the heart tissue. These lesions are designed to block the abnormal electrical signals that trigger AF. The most common ablation strategy is called pulmonary vein isolation (PVI). The pulmonary veins are four blood vessels that bring oxygen-rich blood from the lungs to the left atrium, and they are a frequent source of the abnormal electrical triggers that start AF. By creating a ring of scar tissue (circumferential lesions) around the opening of each vein, doctors aim to electrically isolate these triggers.
PVI has become a first-line treatment for symptomatic, drug-refractory AF. However, despite advances in technology and technique, success rates remain only moderate over the short and medium term. Many patients experience recurrence of AF after their first procedure and require additional treatment.
Why Some Patients Need a Second Ablation Procedure
When AF returns after a successful initial ablation, the most common reason is that the ablation lines around the pulmonary veins have developed gaps — small areas where the scar tissue is incomplete and electrical signals can find a path back through the previously isolated area. This is called pulmonary vein reconnection.
Studies have consistently shown that PV reconnection is the main cause of procedural failure. Discontinuities in prior ablation sets are a common underlying mechanism for the resumption of electrical conduction. However, during a repeat procedure, identifying these gaps has traditionally been challenging. Doctors currently rely on electrical mapping techniques — using catheters to measure voltage within the heart and find the exact spots where electrical signals are getting through. This process can be time-consuming and sometimes imprecise.
This is where a newer imaging technique comes into play. Delayed-enhancement cardiac magnetic resonance (DE-CMR) is a specialized type of heart MRI that can actually visualize scar tissue (radiofrequency lesions) in the heart muscle. Since it can see where scar tissue is present and, more importantly, where it is missing, DE-CMR has the potential to show gaps in prior ablation lines directly. This study set out to test whether using DE-CMR images to guide a repeat ablation procedure was feasible and useful in real patients.
In 2007, Peters and colleagues first identified radiofrequency-related scarring using this imaging method in the context of PVI, and several subsequent studies confirmed its usefulness. However, the reproducibility of the technique had been questioned. A recent experimental study in a swine model showed how real-time DE-CMR can depict gaps in acute ablation lesion sets and guide ablation. The present study was designed to evaluate whether directly using DE-CMR guidance during repeat ablation procedures in humans could help doctors localize and close gaps more efficiently.
Study Methods: How the Research Was Conducted
The study was conducted at the Hospital Clínic in Barcelona, Spain, and was approved by the hospital's ethics committee. Patients were enrolled prospectively between June 2012 and March 2013.
Study Population
Fifteen consecutive eligible patients were included. All had experienced atrial arrhythmia recurrence after a first pulmonary vein isolation procedure and had an indication for a repeat procedure. The inclusion criteria were:
- Drug-refractory AF or atypical atrial flutter after a first percutaneous PVI procedure (excluding a 3-month blanking period, during which early recurrences are not counted as failures)
- Written informed consent
Patients were excluded if they were under 18 years of age or had a contraindication for a 3-Tesla cardiac MRI, which included advanced renal failure, morbid obesity, having a pacemaker or implantable cardioverter-defibrillator, prior adverse reactions to magnetic contrast agents, or pregnancy.
The study population included 12 men and 3 women with a mean age of 57 ± 8 years. Nine patients (60%) had paroxysmal AF (episodes that come and go and stop on their own within 7 days), while the remaining patients had persistent AF. The median time from the prior PVI procedure to the repeat procedure was 15 months (interquartile range [IQR]: 9 to 22 months). The prior procedure had been PVI in all patients, and 8 patients had also undergone a roof-line ablation (an additional lesion line across the top of the left atrium designed to block certain types of abnormal circuits).
Additionally, 15 consecutive clinically matched patients who underwent a second conventional ablation using the standard Lasso-technique (a circular mapping catheter) with the same operators served as a control group for comparison of procedural outcomes.
MRI Imaging and Image Processing
Each patient underwent a pre-procedure 3-dimensional (3D) DE-CMR scan. The scan used a respiratory-navigated (free-breathing) and electrocardiographically gated inversion-recovery gradient-echo sequence, which means the MRI compensated for breathing motion and timed image capture to the heartbeat. The voxel (3D pixel) size was 1.25 × 1.25 × 2.5 mm, a high resolution that allows detection of very small structural details.
After the scan, an experienced observer who was masked to clinical information manually traced the outer (epicardium) and inner (endocardium) borders of the heart's left atrium on each image slice. Using specialized software, the full left atrial volume was reconstructed in 3D. Five concentric surface layers were then created automatically — positioned at 10%, 25%, 50%, 75%, and 90% of the left atrial wall thickness (an "onion skin" model).
A pixel signal intensity (SI) map was projected onto each layer and color-coded. Each shell contained an average of 60,000 triangles with a mean edge length of 0.45 mm. To identify prior ablation lesions and gaps, a pixel-SI-based algorithm classified areas as scar core or border zone using thresholds of 40 ± 5% and 60 ± 5% of maximum intensity. A CMR gap was defined as any discontinuity in the previous ablation scar core, and was quantified by gap length in millimeters. Border zone tissue was not counted as a gap.
The final processed images were used to create a DE-CMR model that was integrated into the CARTO 3 navigation system — a 3D mapping platform commonly used during ablation procedures. This allowed the doctor performing the ablation to see the MRI-based scar and gap information directly on the navigation screen during the procedure.
The Repeat Ablation Procedure
In the repeat ablation procedure, standard institutional protocols for sedation and anticoagulation were used. If AF was present at the time of the procedure, electrical cardioversion (a controlled electric shock to restore normal rhythm) was performed.
First, a very detailed voltage map was created for each patient using the CARTO 3 system and a 3.5-mm, open-irrigation tip, contact-force sensing catheter. Importantly, to avoid false low-voltage readings, mapping points were only collected when the catheter had a contact force above 10 grams — ensuring reliable tissue contact.
Then, a circular multipolar mapping catheter (the Lasso catheter) was introduced to identify sites of pulmonary vein reconnection. The reconnection sites were identified as the earliest PV electrogram in the activation sequence at the vein's entrance. A second operator then ablated the CMR gaps — but crucially, this operator was blinded to the circular mapping catheter and voltage mapping information. The operator was guided only by the color-coded DE-CMR model. For each pulmonary vein, ablation continued until electrical isolation was achieved. The roof line (in patients who had one from the previous procedure) was also checked, and additional ablation was performed if needed to achieve conduction block.
Statistical Analysis
Continuous data were reported as mean ± standard deviation (SD), median, or interquartile range as appropriate. Nominal data were reported as counts and percentages. The chi-square or Fisher exact test compared proportions between groups, and Student t, paired t, Friedman, or Mann-Whitney U tests were used for continuous variables. A p-value of ≤ 0.05 was considered statistically significant. All analyses used SPSS 18.0 software.
Key Findings: What the MRI Detected
CMR Gap Locations and Sizes
In the 15 patients, a total of 56 pulmonary veins were identified. A left common trunk (a normal anatomical variant in which the left superior and left inferior veins join together before entering the left atrium) was found in 4 patients. The remaining 11 patients had 4 independent pulmonary vein openings.
Gap characterization was performed in 53 pulmonary veins (3 veins were excluded because there was a complete absence of scarring around them). The researchers identified a total of 67 CMR gaps around the pulmonary veins, which worked out to a mean of 4.47 gaps per patient and 1.27 ± 0.41 gaps per pulmonary vein.
Not all veins were equally affected. The right superior pulmonary vein had the highest number of gaps (mean of 1.53 gaps), while the left inferior pulmonary vein had the fewest (mean of 0.67 gaps). The median gap length was 13.33 ± 5.8 mm per gap, with a minimum detected gap length of just 1.6 mm. The majority of patients (73.3%) had CMR gaps in all of their pulmonary veins.
These findings highlight an important reality: after a single PVI procedure, complete and continuous scar encircling every vein is actually rare. In fact, prior research referenced in this study found that only about 7% of patients have complete encircling lesions around all their pulmonary veins after one ablation. The present study confirms that gaps are extremely common — all patients had at least one gap, and in most patients every vein had at least one gap.
Pulmonary Vein Reconnection and MRI Concordance
Of the 56 pulmonary veins, 49 were electrically reconnected at the time of the repeat procedure. All of these reconnected veins showed CMR gaps (46 veins) or a complete absence of scarring (3 veins). The remaining 7 veins were still electrically isolated; of these, 3 showed CMR gaps (suggesting areas of incomplete scar that had not yet formed a conducting path) and 4 had complete encircling lesions with no gaps.
The electrogram-CMR concordance was 94.6% (53 of 56 pulmonary veins). In only 3 veins (5.4%) did the MRI show gaps in veins that were still electrically isolated — meaning the MRI detected anatomical gaps that weren't yet electrically active.
Critically, the researchers assessed whether the exact location of electrical reconnection matched the location of the MRI-detected gaps. In the 18 pulmonary veins where the position of the circular mapping catheter was strictly perpendicular to the vein's opening (allowing precise localization), the site of earliest electrical activation matched a CMR gap in 79% of pulmonary veins. Interestingly, in some cases the MRI-guided ablation at a CMR gap successfully re-isolated the vein even when the Lasso catheter's earliest activation point was at a different location — suggesting the MRI was providing information the electrical mapping alone could not reliably identify.
In 8 pulmonary veins (14.3%), advancing the circular mapping catheter into the vein was not technically feasible. This included 4 left inferior pulmonary veins, 2 right inferior pulmonary veins, and 2 left superior pulmonary veins. In one case, a pulmonary vein stenosis (narrowing from the prior ablation) caused the failure — the left superior vein measured just 0.6 cm in diameter. The other veins were of normal size (mean 16.1 ± 2.3 mm), but a sharp angle between the vein and the atrium, or an excessively superior transseptal puncture, made cannulation impossible. This is precisely the kind of situation where an imaging-based approach that doesn't require entering the vein could be especially valuable.
Findings for the Roof Line Ablation
Eight patients in the study had undergone a roof line ablation during their first procedure. The roof line is an additional ablation line along the top of the left atrium, which is sometimes added to block re-entrant electrical circuits that can cause atrial flutter or contribute to AF recurrence.
At the time of the repeat procedure, only 1 patient had persistent conduction block through the roof line, and correspondingly this patient had no CMR gaps at the roof line. The other 7 patients all showed conduction resumption (the electrical signal was getting through again). Of these, 5 patients had CMR gaps visible at the roof line, and 2 patients showed a complete absence of scarring — meaning the roof line had essentially disappeared entirely.
The most common location for roof-line gaps was the right aspect of the roof line (60%). Two patients had gaps at the left aspect or the middle of the line. The mean length of the roof-line gaps was 21 ± 11 mm.
Using the DE-CMR model as guidance, the operators successfully achieved bidirectional conduction block through the roof line in all patients, with a median radiofrequency time of just 1.4 minutes (interquartile range: 0.7 to 3.1 minutes). This demonstrates that DE-CMR can also accurately guide ablation of additional lines beyond the pulmonary veins.
Comparing MRI Gaps with Electrical Mapping
The researchers obtained a very high-density voltage map in all patients, with a mean of 808 mapping points per patient (range: 520 to 1,004 points). This high density is important because it reduces the need for interpolation (mathematical "filling in" between measured points), which can hide actual gaps.
The median voltage measurements were distinctly different across tissue types:
- Scar tissue: 0.21 mV (interquartile range: 0.10 to 0.36 mV)
- Border zone: 0.31 mV (interquartile range: 0.17 to 0.51 mV)
- Healthy myocardium: 0.44 mV (interquartile range: 0.24 to 0.99 mV)
These differences were highly statistically significant (p < 0.001), confirming that the voltage map could distinguish scarred from healthy tissue. When the researchers compared gap identification between the two techniques (available for 10 patients), they found that DE-CMR identified significantly more gaps than the voltage map: a mean of 7.2 ± 2.7 gaps per patient versus 5.5 ± 2.1 gaps per patient (p = 0.016). The agreement between the two techniques was 76 ± 24%.
The fact that DE-CMR detected more gaps than voltage mapping suggests that some anatomical gaps may not be electrically evident at the time of the procedure — they may be dormant areas that could become conducting later. This is a potentially important advantage. A voltage map can only show what is electrically active at that exact moment, while the MRI shows the structure itself. Some CMR-detected gaps in electrically isolated veins might become reconnected over time, which could explain late recurrences.
The researchers also noted that their results differed from a previous study by Spragg and colleagues, which had reported that DE-CMR could identify the reconnection site in only 28% of pulmonary veins. The authors attribute the difference to multiple methodological improvements: they used a 3-Tesla scanner with a 32-channel cardiac coil (optimizing the signal-to-noise ratio), they used fully automated pixel-intensity-based analysis rather than manual visual assessment, and they segmented the entire left atrial wall rather than just visually hyper-enhanced areas. Given the very thin atrial wall, these technical details matter substantially.
MRI-Guided Re-Ablation Results
Of the 46 reconnected pulmonary veins that had CMR gaps (not counting the 3 veins with complete absence of scarring), 44 (95.6%) were successfully re-isolated using only the DE-CMR model as guidance — that is, without any input from the circular mapping catheter or voltage information. This is a remarkably high success rate that validates the accuracy of the MRI-based approach.
In 14 veins (30.4%), isolation was achieved even before the operators had finished ablating all of the MRI-identified gaps. This suggests that not every gap needed to be ablated to achieve electrical isolation — some gaps may be electrically dormant, and closing the "active" ones was sufficient. In the 3 pulmonary veins with complete absence of scarring, the operators deployed complete circumferential lesions guided by the MRI model. Only 2 veins (4.4%) required the circular mapping catheter to identify the reconnection site when MRI-guided ablation alone was insufficient.
The median radiofrequency time required to achieve conduction block in all reconnected veins was 13.3 minutes per patient (interquartile range: 7.5 to 21.7 minutes), or about 4.2 minutes per pulmonary vein. For the roof line, the median RF time was 1.4 minutes (IQR: 0.7 to 3.1 minutes) as noted earlier.
Comparison with Conventional Procedures
To determine whether the MRI-guided approach offered practical benefits, the researchers compared outcomes with 15 control patients who underwent a conventional repeat PVI procedure using the standard Lasso-catheter technique with the same operators. The results were as follows:
- Radiofrequency time: Significantly shorter with the MRI-guided approach — 930 ± 662 seconds versus 1,441 ± 915 seconds in the control group (p = 0.026). This represents roughly a 35% reduction in RF time.
- Total procedural duration: Not significantly different — 166 ± 65 minutes for the MRI-guided approach versus 177 ± 50 minutes for the conventional approach (p = 0.633).
- Fluoroscopy time: Not significantly different — 14 minutes (IQR: 10 to 18 minutes) for the MRI-guided approach versus 18 minutes (IQR: 11 to 27 minutes) for the conventional approach (p = 0.343).
So, the main measurable benefit was a significant reduction in the amount of radiofrequency energy needed — meaning fewer burns and potentially less damage to healthy heart tissue — without sacrificing effectiveness or safety.
Follow-Up Results
The median time from the MRI scan to the ablation procedure was 7 days (interquartile range: 1 to 16 days), showing that the imaging could be incorporated into clinical workflow without long delays. After a mean follow-up of 8.5 ± 4.1 months, 3 patients (20%) had experienced AF recurrence beyond the standard 3-month blanking period. This outcome is at least comparable to historical results with conventional techniques and suggests the MRI-guided approach doesn't sacrifice long-term efficacy for its procedural advantages.
Clinical Implications: What This Means for Patients
This study provides the first evidence in humans that DE-CMR can successfully guide repeat AF ablation procedures by accurately identifying and localizing gaps in prior ablation lesions. For patients facing a second (or subsequent) ablation, this has several potentially important implications:
More precise ablation. Instead of relying solely on electrical mapping to find reconnection sites (which requires entering each vein with a catheter and can miss dormant gaps), doctors could use the MRI map to target gaps directly. The finding that 95.6% of reconnected veins were re-isolated with MRI guidance alone — and that the MRI identified more gaps than electrical mapping — suggests the technique provides complementary, and in some ways superior, information.
Less radiofrequency energy. The significant reduction in RF time (930 vs. 1,441 seconds, p = 0.026) means patients receive fewer burns during the procedure. This could theoretically reduce the risk of damage to surrounding structures, such as the esophagus, phrenic nerve, or healthy atrial tissue, and potentially reduce post-procedural inflammation.
Help when vein access is difficult. In the 14.3% of veins where a circular mapping catheter could not be positioned, the MRI-guided approach still allowed successful ablation. For patients with challenging anatomy, PV stenosis, or sharp angles, this is a meaningful advantage.
Potential to reduce repeat procedures. The study's observation that MRI-detected gaps in electrically isolated veins might represent dormant gaps that could eventually reconnect suggests that a more complete ablation of all gaps (guided by MRI) might reduce the likelihood of late reconnection and thus reduce the need for further procedures. This hypothesis requires confirmation in larger studies, but it is an exciting possibility.
Limitations of the technique. It's important for patients to understand that this is an emerging technology. The study was small (15 patients), was conducted at a single center, and the follow-up period was relatively short. The technique also requires significant expertise and specialized software for image processing, and not every hospital has access to high-resolution 3-Tesla MRI with cardiac coils and advanced post-processing tools.
Study Limitations
As with any clinical study, this research has limitations that patients should understand when interpreting the results:
- Small sample size: Only 15 patients were included in the prospective group, and 15 in the control group. This limits the statistical power and the generalizability of the findings.
- Single-center experience: All procedures were performed at one institution with specific expertise in both cardiac MRI and complex ablation. Results may differ at other centers with less experience.
- No randomization: The control group was not randomly assigned; patients were "clinically matched" retrospectively. Although the authors selected consecutive controls from the same operators, there could be unmeasured differences between the groups.
- Operator blinding was one-directional: The ablation operator was blinded to electrical data during CMR-guided ablation, but the study was not designed to mask the control procedures in a similar way, and the overall team was not blinded to the study's purpose.
- Short follow-up: The mean follow-up of 8.5 months is relatively short, and some late recurrences may not have been captured.
- Technical complexity: Manual segmentation of the atrial wall requires training and time, and the authors noted that an automated approach was used to reduce operator-dependent assessment. However, this still requires specialized software that isn't widely available.
- Unanswered questions: The study identified CMR gaps in some veins that were still electrically isolated. Whether these represent dormant gaps that eventually reconnect (and thus should be ablated) is unknown and warrants further research.
Recommendations for Patients
If you are facing a repeat atrial fibrillation ablation procedure, here is what you should know based on this research:
- Ask about advanced imaging options. Not every center offers DE-CMR-guided ablation, but if you are scheduled for a repeat procedure, ask whether a pre-procedure cardiac MRI to map scar tissue might be available or beneficial in your case.
- Understand the goal of a repeat procedure. A repeat ablation is usually simpler and more targeted than the first one. Doctors are typically looking for and closing gaps in the previous ablation lines — and this study suggests imaging can help make that process more precise.
- Know the expected success rates. In this study, 80% of patients were free from AF recurrence at a mean follow-up of 8.5 months (3 of 15 had recurrence). This is within the range reported for conventional repeat ablation procedures, suggesting the MRI-guided approach maintains efficacy.
- Expect a potentially shorter ablation time. The reduction in radiofrequency time (about 35% less than conventional procedures) could translate to a somewhat shorter and less invasive experience, although total procedure time in this study was similar.
- Ask about the technology used at your center. The MRI technique used in this study required a 3-Tesla scanner, a 32-channel cardiac coil, specialized post-processing software (Tissue Characterization Tool Kit, GIMIAS), and integration with the CARTO 3 navigation system. If you are considering a repeat ablation, it's reasonable to ask whether your center uses integrated imaging to guide the procedure.
- Remember that individual results vary. Every patient's anatomy and prior ablation are different. What worked well in this study population may not apply to everyone, and your electrophysiologist will tailor the approach to your specific situation.
- Continue standard follow-up care. Even with the most advanced guidance, AF can recur. This study used a 3-month blanking period (early recurrences weren't counted as failures) and ongoing monitoring. Keep up with your scheduled follow-up visits and report any symptoms promptly.
In summary, this study represents an important step forward in making repeat AF ablation procedures more precise and potentially less invasive. By directly visualizing the gaps in prior ablation lines, DE-CMR guidance allowed doctors to close those gaps efficiently — with less radiofrequency energy and without sacrificing success rates. While larger, randomized studies are needed to confirm these findings, the results are encouraging for the many patients who need a second procedure to achieve lasting freedom from atrial fibrillation.
Frequently Asked Questions
What is delayed-enhancement cardiac magnetic resonance (DE-CMR)?
DE-CMR is a specialized heart MRI that can visualize scar tissue, including the tiny burns made during ablation. In a study of 15 patients having a repeat atrial fibrillation ablation, doctors used DE-CMR images to see where previous ablation lines had gaps. This imaging allowed them to target those gaps directly during the procedure, without relying only on electrical mapping.
Why might I need a second ablation for atrial fibrillation?
After a first ablation, the most common reason atrial fibrillation returns is that gaps form in the scar lines around the pulmonary veins, allowing electrical signals to reconnect. In a study of 15 patients undergoing a repeat procedure, all had at least one gap, and most had gaps in every vein. Closing these gaps can restore isolation.
Does MRI-guided ablation reduce procedure risks or recovery time?
In a study of 15 patients, MRI-guided ablation significantly shortened radiofrequency energy time by about 35% compared with conventional procedures, meaning fewer burns to heart tissue. Total procedure time and fluoroscopy time were similar. The study did not report specific recovery details, but less radiofrequency energy might theoretically reduce damage to surrounding structures. Discuss individual risks with your doctor.
What does it mean if the MRI shows a gap but the vein is still electrically isolated?
In a study of 15 patients, MRI detected gaps in some pulmonary veins that were still electrically isolated, meaning the gap was not yet conducting electricity. Researchers suggested these might be dormant gaps that could reconnect later and cause late recurrence. Whether these gaps should be ablated is unknown and requires further research. Your doctor can help interpret such findings.
Can MRI-guided ablation help if my veins are difficult to access with a catheter?
Yes, potentially. In a study of 15 patients, 14.3% of pulmonary veins could not be accessed with a circular mapping catheter due to narrowings, sharp angles, or other anatomy. The MRI-guided approach still allowed successful ablation in those cases because it does not require entering the vein. This could be an advantage for patients with challenging vein anatomy.
What should I ask my doctor if I'm considering a repeat ablation?
Ask whether your center offers pre-procedure cardiac MRI to map scar tissue and guide the ablation. In a study of 15 patients, this approach reduced radiofrequency time and maintained success rates. Also ask about the technology available, such as a 3-Tesla scanner and specialized software. Remember that individual results vary, and your electrophysiologist will tailor the approach to your situation.
I need a second ablation for atrial fibrillation — when should I get a second opinion about whether MRI-guided gap closure is right for me?
A second opinion is worth seeking when a repeat ablation is being planned and you want to know whether pre-procedure delayed-enhancement cardiac MRI to map scar and gaps is available or appropriate in your case. It is also reasonable if your anatomy makes catheter positioning difficult, since 14.3% of veins in this research could not be cannulated but were still ablated using MRI guidance alone. A second opinion can clarify whether integrated imaging suits your prior ablation lines and pulmonary veins. Diagnostic Detectives Network provides independent expert second opinions.
Source Information
Original article title: CMR-Guided Approach to Localize and Ablate Gaps in Repeat AF Ablation Procedure
Authors: Felipe Bisbal, MD; Esther Guiu, MSC; Pilar Cabanas-Grandío, MD; Antonio Berruezo, MD, PhD; Susana Prat-Gonzalez, MD, PhD; Bárbara Vidal, MD, PhD; Cesar Garrido, RT; David Andreu, MSC, PhD; Juan Fernandez-Armenta, MD; José María Tolosana, MD; Elena Arbelo, MD, PhD; Teresa M. de Caralt, MD, PhD; Rosario J. Perea, MD, PhD; Josep Brugada, MD, PhD; Lluís Mont, MD, PhD
Journal: JACC: Cardiovascular Imaging, Volume 7, No. 7, 2014, pages 653–663
Publication details: Published by the American College of Cardiology Foundation and Elsevier Inc. Manuscript received November 4, 2013; revised manuscript received December 16, 2013; accepted January 10, 2014. The study was supported by the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain, and the European Regional Development Fund (European Union).
Note: This patient-friendly article is based on peer-reviewed research published in a major cardiovascular imaging journal. It is intended for educational purposes and does not constitute medical advice. Patients should discuss their specific treatment options with their healthcare providers. This patient-friendly translation is not affiliated with or endorsed by the original authors or the journal.